National Health Investors (NHI) Tops Q2 EPS by 37c

National Health Investors (NYSE: NHI) reported Q2 EPS of $1.06, $0.37 better than the analyst estimate of $0.69. Revenue for the quarter came in at $77.88 million versus the consensus estimate of $58.86 million.

For earnings history and earnings-related data on National Health Investors (NHI) click here.

You May Also Be Interested In

• ’Ocean of opportunity’: Wolfe initiates SpaceX at Buy ahead of historic IPO
• Wolfe Research Starts SpaceX (SPCX) at Outperform
• RH (RH) Tops Q1 EPS by 12c